|
1
|
Sissons HA: The WHO classification of bone
tumors. Recent Results Cancer Res. 54:104–108. 1976.
|
|
2
|
Mckenna R: Sarcomata of the osteogenic
series (osteosarcoma, fibrosarcoma, chondrosarcoma, parosteal
osteogenic sarcoma, and sarcomata arising in abnormal bone): An
analysis of 552 cases. J Bone Joint Surg Am. 48:1–26. 1966.
View Article : Google Scholar
|
|
3
|
Ries LAG, Smith MA, Gurney JG, Linet M,
Tamra T, Young JL and Bunin GR: Cancer incidence and survival among
children and adolescents: United States SEER Program, 1975–1995.
Bethesda, MD: 1999
|
|
4
|
Stiller CA, Bielack SS, Jundt G and
Steliarova-Foucher E: Bone tumours in European children and
adolescents, 1978–1997. Report from the automated childhood cancer
information system project. Eur J Cancer. 42:2124–2135. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anninga JK, Gelderblom H, Fiocco M, Kroep
JR, Taminiau AH, Hogendoorn PC and Egeler RM: Chemotherapeutic
adjuvant treatment for osteosarcoma: Where do we stand? Eur J
Cancer. 47:2431–2445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bentwich I, Avniel A, Karov Y, Aharonov R,
Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al:
Identification of hundreds of conserved and nonconserved human
microRNAs. Nat Genet. 37:766–770. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhong X, Coukos G and Zhang L: miRNAs in
human cancer. J Pathol. 223:102–115. 2015.
|
|
11
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie L, Jing R, Qi J, Lin Z and Ju S: Drug
resistance-related microRNAs in hematological malignancies:
Translating basic evidence into therapeutic strategies. Blood Rev.
29:33–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Torreggiani E, Roncuzzi L, Perut F, Zini N
and Baldini N: Multimodal transfer of MDR by exosomes in human
osteosarcoma. Int J Oncol. 49:1892016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duan Z, Gao Y, Shen J, Choy E, Cote G,
Harmon D, Bernstein K, Lozano-Calderon S, Mankin H and Hornicek FJ:
miR-15b modulates multidrug resistance in human osteosarcoma in
vitro and in vivo. Mol Oncol. 11:151–166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo S, Bai R, Liu W, Zhao A, Zhao Z, Wang
Y, Wang Y, Zhao W and Wang W: miR-22 inhibits osteosarcoma cell
proliferation and migration by targeting HMGB1 and inhibiting
HMGB1-mediated autophagy. Tumor Biol. 35:7025–7034. 2014.
View Article : Google Scholar
|
|
16
|
Zhou J, Wu S, Chen Y, Zhao J, Zhang K,
Wang J and Chen S: microRNA-143 is associated with the survival of
ALDH1+CD133+ osteosarcoma cells and the chemoresistance of
osteosarcoma. Exp Biol Med. 240:867–875. 2015. View Article : Google Scholar
|
|
17
|
Zhao G, Cai C, Yang T, Qiu X, Liao B, Li
W, Ji Z, Zhao J, Zhao H, Guo M, et al: MicroRNA-221 induces cell
survival and cisplatin resistance through PI3K/Akt pathway in human
osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT,
Liu B and Bao JK: Programmed cell death pathways in cancer: A
review of apoptosis, autophagy and programmed necrosis. Cell
Prolif. 90:487–498. 2012. View Article : Google Scholar
|
|
19
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Knyazev EN, Samatov TR, Fomicheva KA,
Nyushko KM, Alekseev BY and Shkurnikov MY: MicroRNA hsa-miR-4674 in
hemolysis-free blood plasma is associated with distant metastases
of prostatic cancer. Bull Exp Biol Med. 161:112–115. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Damavandi Z, Torkashvand S, Vasei M,
Soltani BM, Tavallaei M and Mowla SJ: Aberrant expression of breast
development-related MicroRNAs, miR-22, miR-132, and miR-212, in
breast tumor tissues. J Breast Cancer. 19:148–155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang P, Zhao ZQ, Guo SB, Yang TY, Chang
ZQ, Li DH, Zhao W, Wang YX, Sun C, Wang Y and Feng W: Roles of
microRNA-22 in suppressing proliferation and promoting sensitivity
of osteosarcoma cells via metadherin-mediated autophagy. Orthop
Surg. 11:285–293. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wan L, Hu G, Wei Y, Yuan M, Bronson RT,
Yang Q, Siddiqui J, Pienta KJ and Kang Y: Genetic ablation of
metadherin inhibits autochthonous prostate cancer progression and
metastasis. Cancer Res. 74:5336–5347. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou X, Natino D, Zhai X, Gao Z and He X:
MicroRNA-22 inhibits the proliferation and migration, and increases
the cisplatin sensitivity, of osteosarcoma cells. Mol Med Rep.
17:7209–7217. 2018.PubMed/NCBI
|
|
25
|
Li Y, Geng P, Jiang W, Wang Y, Yao J, Lin
X, Liu J, Huang L, Su B and Chen H: Enhancement of radiosensitivity
by 5-Aza-CdR through activation of G2/M checkpoint response and
apoptosis in osteosarcoma cells. Tumour Biol. 35:4831–4839. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang TM, Guo SF, Chen CR, Zhang XY and Li
WG: Anti-Osteosarcom aeffects and mechanisms of 4-O-amino-
phenol-4′-demethylepipodophyllotoxin ether. J Pharm Pharmacol.
60:179–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang J, Shen L, Yang Q and Zhang C:
Overexpression of metadherin mediates metastasis of osteosarcoma by
regulating epithelial-mesenchymal transition. Cell Prolif.
47:427–434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ye H, Lin J, Yao X, Li Y, Lin X and Lu H:
Overexpression of long non-coding RNA NNT-AS1 correlates with tumor
progression and poor prognosis in osteosarcoma. Cell Physiol
Biochem. 45:1904–1914. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao S, Chen C, Chang K, Karnad A,
Jagirdar J, Kumar AP and Freeman JW: CD44 expression level and
isoform contributes to pancreatic cancer cell plasticity,
invasiveness, and response to therapy. Clin Cancer Res.
22:5592–5604. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Meng CY, Zhao ZQ, Bai R, Zhao W, Wang YX,
Xue HQ, Sun L, Sun C, Feng W and Guo SB: MicroRNA-22 mediates the
cisplatin resistance of osteosarcoma cells by inhibiting autophagy
via the PI3K/Akt/mTOR pathway. Oncol Rep. 43:1169–1186.
2020.PubMed/NCBI
|
|
31
|
Zou Y, Yang J, Wu J, Luo C and Huang Y:
miR?133b induces chemoresistance of osteosarcoma cells to cisplatin
treatment by promoting cell death, migration and invasion. Oncol
Lett. 15:1097–1102. 2018.PubMed/NCBI
|
|
32
|
Vanas V, Haigl B, Stockhammer V and
Sutterlüty-Fall H: MicroRNA-21 increases proliferation and
cisplatin sensitivity of osteosarcoma-derived cells. PLoS One.
11:e01610232016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Karpel-Massler G, Shu C, Chau L, Banu M,
Halatsch ME, Westhoff MA, Ramirez Y, Ross AH, Bruce JN, Canoll P
and Siegelin MD: Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3
overcomes apoptotic resistance in glioblastoma in vitro and in
vivo. Oncotarget. 6:14507–14521. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu Z, Tang J, Wang J, Duan G, Zhou L and
Zhou X: miR-138 acts as a tumor suppressor by targeting EZH2 and
enhances cisplatin-induced apoptosis in osteosarcoma cells. PLoS
One. 11:e01500262016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ziyan W and Yang L: MicroRNA-21 regulates
the sensitivity to cisplatin in a human osteosarcoma cell line. Ir
J Med Sci. 185:85–91. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gai P, Sun H, Wang G, Xu Q and Jiang L:
miR-22 promotes apoptosis of osteosarcoma cells via inducing cell
cycle arrest. Oncol Lett. 13:2354–2358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li X, Wang S, Chen Y, Liu G and Yang X:
miR-22 targets the 3′ UTR of HMGB1 and inhibits the
HMGB1-associated autophagy in osteosarcoma cells during
chemotherapy. Tumor Biol. 35:6021–6028. 2014. View Article : Google Scholar
|
|
38
|
Yan J, Zhang J, Zhang X, Li X, Li L, Li Z,
Chen R, Zhang L, Wu J, Wang X, et al: AEG-1 is involved in
hypoxia-induced autophagy and decreases chemosensitivity in T-cell
lymphoma. Mol Med. 24:352018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zou M, Zhu W, Wang L, Shi L and Hu G:
AEG-1/MTDH-activated autophagy enhances human malignant glioma
susceptibility to TGF-β1-triggered epithelial-mesenchymal
transition. Oncotarget. 7:13122–13138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pei G, Luo M, Ni X, Wu J, Wang S, Ma Y and
Yu J: Autophagy facilitates metadherin-induced chemotherapy
resistance through the AMPK/ATG5 pathway in gastric cancer. Cell
Physiol Biochem. 46:847–859. 2018. View Article : Google Scholar : PubMed/NCBI
|
